Fe₃O₄@Pt nanoparticles to enable combinational electrodynamic/chemodynamic therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Electrodynamic therapy (EDT) shows promise for tumor treatment but faces challenges from the tumor microenvironment, such as glutathione (GSH) overexpression.
• Current reactive oxygen species (ROS) based therapies are hindered by factors like tumor acidity and high GSH levels, which scavenge ROS.

Purpose of the Study:

• To develop a novel therapeutic strategy by integrating electrodynamic therapy with chemodynamic therapy and GSH depletion.
• To utilize iron oxide nanoparticles decorated with platinum nanocrystals (Fe3O4@Pt NPs) for enhanced tumor treatment.

Main Methods:

• Decoration of iron oxide nanoparticles with platinum nanocrystals (Fe3O4@Pt NPs).
• Induction of ROS generation via electric field-triggered catalytic reactions on Pt nanoparticles.
• Catalysis of intracellular H2O2 into ROS via Fenton reaction using Fe3+ ions.
• Consumption of GSH by released Fe3+ ions in acidic tumor environments to enhance ROS efficacy.

Main Results:

• Fe3O4@Pt NPs effectively induced ROS generation under electric field stimulation.
• The nanoparticles catalyzed intracellular H2O2 into ROS, amplifying the therapeutic effect.
• Released Fe3+ ions consumed GSH, reducing ROS clearance and improving antitumor efficacy.
• Significant in vitro and in vivo tumor inhibition was observed, demonstrating the effectiveness of the combined approach.

Conclusions:

• Fe3O4@Pt NPs offer a novel platform for combining electrodynamic therapy with chemodynamic therapy and GSH depletion.
• This combinational approach overcomes limitations of ROS-based therapies in the tumor microenvironment.
• The study presents a promising alternative therapeutic modality with superior antitumor efficacy.